These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5700097)

  • 21. [Clinical contribution on the hepatorenal syndrome].
    BONIVART A; FOLYOVICH G
    Zentralbl Gynakol; 1957 Jun; 79(25):995-1000. PubMed ID: 13468763
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatorenal syndrome in pregnancy].
    STAMM H; MOSER E; KELLER M
    Gynaecologia; 1957 Dec; 144(6):375-84. PubMed ID: 13512764
    [No Abstract]   [Full Text] [Related]  

  • 23. [The hepatorenal syndrome].
    Ubelhör R
    Wien Klin Wochenschr; 1965 Sep; 77(38):678-9. PubMed ID: 5864190
    [No Abstract]   [Full Text] [Related]  

  • 24. On the validity of the hepatorenal syndrome] (Hun.
    Trencséni T
    Orv Hetil; 1966 Oct; 107(41):1929-31. PubMed ID: 5978535
    [No Abstract]   [Full Text] [Related]  

  • 25. Metaraminol in "hepatorenal syndrome".
    Sugerman HJ; Berkowitz HD; Miller LD; Schapiro RH; Fischer J
    N Engl J Med; 1971 Jul; 285(3):180-1. PubMed ID: 5087714
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter: Hepatorenal syndrome and prolactin.
    Horrobin DF; Manku MS; Nassar BA
    N Engl J Med; 1974 Feb; 290(7):408. PubMed ID: 4810128
    [No Abstract]   [Full Text] [Related]  

  • 27. [The hepatorenal syndrome: etiopathogenetic, clinical and therapeutic considerations].
    Mancinella A
    Clin Ter; 1976 Dec; 79(6):583-90. PubMed ID: 795602
    [No Abstract]   [Full Text] [Related]  

  • 28. [Water and salt metabolism in liver disease and the hepatorenal syndrome].
    Modai D
    Harefuah; 1974 Jun; 86(12):614-5. PubMed ID: 4411510
    [No Abstract]   [Full Text] [Related]  

  • 29. [Modern approach to the hepatorenal syndrome].
    Dzioba H
    Wiad Lek; 1965 Jun; 18(12):979-84. PubMed ID: 5832653
    [No Abstract]   [Full Text] [Related]  

  • 30. Significance of altered renin substrate in the hepatorenal syndrome.
    Berkowitz HD; Galvin C; Miller LD
    Surg Forum; 1972; 23(0):342-3. PubMed ID: 4671111
    [No Abstract]   [Full Text] [Related]  

  • 31. Urinary excretion of prostaglandins and thromboxanes in the hepatorenal syndrome.
    Kronborg IJ; Radvan G; Zipser RD
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():539-42. PubMed ID: 6221576
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pathophysiology and diagnosis of the acute hepatorenal syndrome in surgery].
    Lebedeva RN; Abbakumov VV; Tret'iakova ES; Svirshchevskiĭ EB
    Anesteziol Reanimatol; 1984; (5):30-3. PubMed ID: 6517369
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatorenal syndrome--clinical analysis of 68 cases and a pathological study of 48 cases].
    Qiu XN
    Zhonghua Nei Ke Za Zhi; 1984 Sep; 23(9):558-60. PubMed ID: 6532701
    [No Abstract]   [Full Text] [Related]  

  • 34. Editorial: Hepatorenal and glomerulotubular imbalance.
    Bradley SE
    N Engl J Med; 1973 Nov; 289(22):1194-5. PubMed ID: 4585363
    [No Abstract]   [Full Text] [Related]  

  • 35. Renin substrate infusions in hepatorenal syndrome.
    McCombs PR; Berkowitz HD; Miller LD; Rosato EF
    Surg Forum; 1975; 26():419-21. PubMed ID: 56050
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of refractory ascites and the hepatorenal syndrome by the LeVeen peritoneo-venous shunt.
    Wapnick S
    Cent Afr J Med; 1978 Sep; 24(9 Suppl):42-6. PubMed ID: 719744
    [No Abstract]   [Full Text] [Related]  

  • 37. Prolonged hemoperfusion and hemodialysis in management of hepatic failure and hepatorenal syndrome.
    Krumlovsky FA; del Greco F; Niederman M
    Trans Am Soc Artif Intern Organs; 1978; 24():235-8. PubMed ID: 716004
    [No Abstract]   [Full Text] [Related]  

  • 38. [Postoperative hepatorenal syndrome].
    Lebedeva RN; Tret'iakova ES; Abbakumov VV
    Khirurgiia (Mosk); 1974 Nov; 0(11):81-5. PubMed ID: 4431192
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal vasodilator therapy in the hepatorenal syndrome.
    Cohn JN; Tristani FE; Khatri IM
    Med Ann Dist Columbia; 1970 Jan; 39(1):1-7. PubMed ID: 5262172
    [No Abstract]   [Full Text] [Related]  

  • 40. Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors.
    Zipser RD; Radvan GH; Kronborg IJ; Duke R; Little TE
    Gastroenterology; 1983 Apr; 84(4):697-703. PubMed ID: 6572162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.